WASHINGTON — It took just three short paragraphs for Robert Califf to earn the public support of an undecided senator for his bid to become the next commissioner of the Food and Drug Administration.
Sen. Ron Wyden (D-Ore.), the powerful chair of the Senate Finance Committee, announced Thursday that he would support Califf’s nomination. His decision came just days after he implied he would need additional commitments about how the nominee would crack down on companies that thwart the rules of the FDA’s so-called accelerated approval pathway before voting to confirm him as the head of the agency.
Create a display name to comment
This name will appear with your comment